Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.35 USD | +1.11% | +7.97% | -35.86% |
22/04 | Sector Update: Health Care Stocks Increase Late Afternoon | MT |
22/04 | Sector Update: Health Care Stocks Rise in Monday Afternoon Trading | MT |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.63 times the sales for the current fiscal year, the company turns out to be overvalued.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.86% | 2.11B | C | ||
-20.45% | 10.82B | A- | ||
+43.17% | 3.25B | D+ | ||
-17.21% | 2.08B | - | B- | |
-29.81% | 1.48B | C+ | ||
+17.56% | 1.02B | B- | ||
-4.37% | 733M | C+ | ||
-37.00% | 391M | C- | ||
-46.94% | 383M | C- | ||
+13.32% | 332M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GH Stock
- Ratings Guardant Health, Inc.